肝硬化患者肠道中双歧杆菌等减少或消失,大肠杆菌等增加并转为优势菌,可导致血内毒素升高;肠道菌群紊乱与肝功能损害程度密切相关。因此,正确使用微生态制剂可以维护肝硬化患者的肠道微生态平衡,减少内毒素的产生与吸收,对稳定病情将起着积极作用。 Bifidobacteria in the intestine of patients with cirrhosis decreased or disappeared, Escherichia coli and other increased and converted to dominant bacteria, can lead to increased blood endotoxin; Intestinal flora and liver damage is closely related to the degree of damage. Therefore, the proper use of probiotics can maintain the intestinal microflora balance of patients with cirrhosis and reduce the production and absorption of endotoxin, which will play a positive role in stabilizing the disease.